Biportal endoscopic versus microscopic discectomy for lumbar herniated disc: a randomized controlled trial

医学 Oswestry残疾指数 随机对照试验 可视模拟标度 神经根痛 物理疗法 腰椎 外科 不利影响 生活质量(医疗保健) 腰痛 背痛 置信区间 内科学 替代医学 护理部 病理
作者
Sang‐Min Park,Ho-Jin Lee,Hyun‐Jin Park,Jun-Young Choi,Ohsang Kwon,Sanghoon Lee,Ho‐Joong Kim,Jin S. Yeom
出处
期刊:The Spine Journal [Elsevier BV]
卷期号:23 (1): 18-26 被引量:48
标识
DOI:10.1016/j.spinee.2022.09.003
摘要

Biportal endoscopic discectomy has been frequently performed in recent years and has shown acceptable clinical outcomes. However, evidence regarding its efficacy and safety remains limited.This study aimed to compare the clinical efficacy and safety of biportal endoscopic with that of open microscopic discectomy in patients with single-level herniated lumbar discs.Prospective, randomized, multicenter, open-label, assessor-blind, non-inferiority controlled trial.Sixty-four participants suffering from low back and leg pain with a single-level herniated lumbar disc and required discectomy.Outcomes were assessed with the use of patient-reported outcome measures (PROMs), visual analog scale (VAS) pain score for surgical site, low back and lower extremity, Oswestry Disability Index (ODI) for lumbar disabilities, European Quality of Life-5 Dimensions value for quality of life, and painDETECT for neuropathic pain. Surgery-related outcomes such as hospital stay, operation time, and opioid usage were collected. Adverse events occurring during the follow-up period were also noted.All participants were randomly assigned in a 1:1 ratio to undergo biportal endoscopic (biportal group) or microscopic discectomy (microscopy group). The primary outcome was the difference in ODI scores at 12-months post surgically based on a modified intention-to-treat strategy, with a non-inferiority margin of 12.8 points. The secondary outcomes included PROMs, surgery-related outcomes, and adverse events.The ODI score at the 12-month follow-up was 11.97 in the microscopy group and 13.89 in the biportal group (mean difference, 1.92; 95% confidence interval [CI], -3.50 to 7.34), showing the non-inferiority of biportal group. The results for the secondary outcomes were similar to those for the primary outcome. Creatinine phosphokinase ratios were low in the biportal group. Early surgical site pain was slightly lower in the biportal group (mean difference of VAS pain score at 48-hr, -0.98; 95% CI, -1.77 to -0.19). Adverse events including reoperation showed no significant difference between the groups.Biportal endoscopic discectomy was non-inferior to microscopic discectomy over a 12 month period. Biportal endoscopic discectomy is suggested to be a relatively safe and effective surgical technique with the slight advantage of reduced muscle damage. However, the clinical implications of surgical site pain should be carefully considered.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
微微发布了新的文献求助10
刚刚
1秒前
ajs完成签到,获得积分10
1秒前
3秒前
李爱国应助哈哈哈采纳,获得10
4秒前
袁子晴完成签到,获得积分10
4秒前
科研天才完成签到,获得积分10
6秒前
6秒前
眰晌完成签到 ,获得积分10
7秒前
7秒前
马关维完成签到 ,获得积分10
9秒前
9秒前
9秒前
9秒前
10秒前
安诺完成签到,获得积分10
12秒前
NNNi完成签到,获得积分10
12秒前
lyc完成签到,获得积分10
13秒前
幽默翠桃发布了新的文献求助10
13秒前
kevinave完成签到 ,获得积分10
14秒前
AHND发布了新的文献求助10
14秒前
during发布了新的文献求助30
16秒前
CuiHe发布了新的文献求助10
16秒前
zhoujing完成签到 ,获得积分10
17秒前
小马甲应助香菜采纳,获得10
17秒前
高贵三颜发布了新的文献求助10
17秒前
15发布了新的文献求助10
20秒前
科研通AI6.2应助嘻哈师徒采纳,获得10
20秒前
大无畏完成签到,获得积分10
20秒前
思源应助外向铃铛采纳,获得10
20秒前
22秒前
香蕉觅云应助幽默翠桃采纳,获得30
22秒前
CuiHe完成签到,获得积分20
23秒前
木易发布了新的文献求助10
23秒前
24秒前
24秒前
26秒前
27秒前
28秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Introducing the Learning Sciences 600
Resiliency Scale for Adolescents--Chinese Version 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7321602
求助须知:如何正确求助?哪些是违规求助? 8937167
关于积分的说明 18947534
捐赠科研通 6979688
什么是DOI,文献DOI怎么找? 3214793
关于科研通互助平台的介绍 2382407
邀请新用户注册赠送积分活动 2194067